Dark | Light
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

# ![@NEJM Avatar](https://lunarcrush.com/gi/w:26/cr:twitter::25950355.png) @NEJM NEJM

NEJM posts on X about events, history, withdrawal, red the most. They currently have XXXXXXX followers and XX posts still getting attention that total XXXXXX engagements in the last XX hours.

### Engagements: XXXXXX [#](/creator/twitter::25950355/interactions)
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::25950355/c:line/m:interactions.svg)

- X Week XXXXXXX -XX%
- X Month XXXXXXX -XX%
- X Months XXXXXXXXX +78%
- X Year XXXXXXXXX -XX%

### Mentions: XX [#](/creator/twitter::25950355/posts_active)
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::25950355/c:line/m:posts_active.svg)

- X Week XX +7.70%
- X Month XX +13%
- X Months XXX +149%
- X Year XXX +50%

### Followers: XXXXXXX [#](/creator/twitter::25950355/followers)
![Followers Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::25950355/c:line/m:followers.svg)

- X Week XXXXXXX +0.14%
- X Month XXXXXXX -XXXX%
- X Months XXXXXXX +0.06%
- X Year XXXXXXX -XXXX%

### CreatorRank: XXXXXXX [#](/creator/twitter::25950355/influencer_rank)
![CreatorRank Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::25950355/c:line/m:influencer_rank.svg)

### Social Influence

**Social category influence**
[finance](/list/finance)  XXXX% [countries](/list/countries)  XXXX%

**Social topic influence**
[events](/topic/events) #721, [history](/topic/history) 4.55%, [withdrawal](/topic/withdrawal) 4.55%, [red](/topic/red) 2.27%, [education](/topic/education) 2.27%, [express](/topic/express) 2.27%, [level](/topic/level) 2.27%, [history of](/topic/history-of) 2.27%, [insurance](/topic/insurance) 2.27%, [united states](/topic/united-states) XXXX%

**Top accounts mentioned or mentioned by**
[@ashhematology](/creator/undefined) [@erictopol](/creator/undefined) [@doc_blocke](/creator/undefined) [@vfd_org](/creator/undefined) [@svinsociety](/creator/undefined) [@nishantuppal7](/creator/undefined) [@drrishabhonco](/creator/undefined) [@bllphd](/creator/undefined) [@patientstormdoc](/creator/undefined) [@dglaucomflecken](/creator/undefined) [@nejmevidence](/creator/undefined) [@srm128](/creator/undefined) [@asnkidney](/creator/undefined) [@nufeinbergmed](/creator/undefined) [@uabnews](/creator/undefined) [@umasschan](/creator/undefined) [@uwmedicine](/creator/undefined) [@cidrap](/creator/undefined) [@catharinazkh](/creator/undefined) [@nbahlis](/creator/undefined)
### Top Social Posts
Top posts by engagements in the last XX hours

"Presented at #ASH25: In untreated chronic lymphocytic leukemia fixed-duration venetoclax-based regimens were noninferior to continuous ibrutinib with regard to 3-year progression-free survival and were associated with higher MRD-negative rates. Full CLL17 phase X trial results: @ASH_hematology"  
[X Link](https://x.com/NEJM/status/1997298737182617884)  2025-12-06T13:35Z 933.1K followers, 19.7K engagements


"A trial of pegcetacoplan a C3 and C3b inhibitor in patients with C3 glomerulopathy or primary immune-complex membranoproliferative glomerulonephritis showed that the drug significantly reduced proteinuria. Full VALIANT phase X trial results: Editorial: Pegcetacoplan for Treatment of C3 Glomerulopathy and Immune-Complex MPGN"  
[X Link](https://x.com/NEJM/status/1996346241643651573)  2025-12-03T22:30Z 933.1K followers, 13.7K engagements


"Treatments are needed for C3 glomerulopathy and primary immune-complex membranoproliferative glomerulonephritis. Pegcetacoplan a targeted C3 and C3b inhibitor showed promise in phase X trials. Research findings from the VALIANT phase X trial are summarized in a new Quick Take video"  
[X Link](https://x.com/NEJM/status/1997758101613883813)  2025-12-07T20:00Z 933.1K followers, 14.5K engagements


"Presented at #ASH25: In relapsed or refractory T-cell acute lymphoblastic leukemia off-the-shelf allogeneic base-edited CAR7 T cells mediated responses in XX patients enabling stem-cell transplantation in X patients in deep remission. Full study results: @ASH_hematology"  
[X Link](https://x.com/NEJM/status/1998144320512397526)  2025-12-08T21:35Z 933.1K followers, 38.4K engagements


"Presented at #ASH25: In a new study gene editing with a prime editor was used to treat two persons with chronic granulomatous disease caused by a small deletion in the gene NCF1. Full study results: @ASH_hematology"  
[X Link](https://x.com/NEJM/status/1997653576827728037)  2025-12-07T13:05Z 933.1K followers, 31.8K engagements


"Original Article: Fixed-Duration versus Continuous Treatment for Chronic Lymphocytic Leukemia (CLL17 phase X trial) #ASH25 @ASH_hematology"  
[X Link](https://x.com/NEJM/status/1997668436017901611)  2025-12-07T14:04Z 933.1K followers, 32.6K engagements


"Brief Report: Prime Editing for p47-Deficient Chronic Granulomatous Disease #ASH25 @ASH_hematology"  
[X Link](https://x.com/NEJM/status/1998014214783586368)  2025-12-08T12:58Z 933.1K followers, 14.7K engagements


"Presented at #ASH25: In the VAYHIT2 phase X trial ianalumab plus eltrombopag led to a longer time to treatment failure than placebo plus eltrombopag with a stable platelet response at X months in a higher percentage of patients with X mg/kg of ianalumab than with placebo. Full trial results: @ASH_hematology"  
[X Link](https://x.com/NEJM/status/1998370810927714582)  2025-12-09T12:35Z 933.1K followers, 13.1K engagements


"A new trial of pegcetacoplan a C3 and C3b inhibitor in patients with C3 glomerulopathy or primary immune-complex membranoproliferative glomerulonephritis showed that the drug significantly reduced proteinuria. Full VALIANT phase X trial results and Research Summary:"  
[X Link](https://x.com/NEJM/status/1998754758342095031)  2025-12-10T14:00Z 933.1K followers, 8851 engagements


"A 26-year-old woman was referred to the pulmonary hypertension clinic with a 6-month history of exertional dyspnea and hoarseness. Vocal-fold paralysis was seen on laryngoscopy (shown in a video). Read the full case details:"  
[X Link](https://x.com/NEJM/status/1993409480445640739)  2025-11-25T20:00Z 932.9K followers, 636.8K engagements


"Original Article: Early Discontinuation of Aspirin after PCI in Low-Risk Acute Myocardial Infarction (TARGET-FIRST trial) Editorial: Discontinuation of Aspirin in Acute Coronary Syndromes Treated with Coronary-Artery Stents #Cardiology"  
[X Link](https://x.com/NEJM/status/1994768507419189628)  2025-11-29T14:00Z 932.8K followers, 35.9K engagements


"In a new trial one dose of an HPV vaccine was noninferior to two doses in preventing HPV type XX or XX infection. Full ESCUDDO trial results: Editorial: Evidence to Action Single-Dose HPV Vaccination and Cervical HPV Infection"  
[X Link](https://x.com/NEJM/status/1996342447379767750)  2025-12-03T22:15Z 933K followers, 15.8K engagements


"A baby boy was transferred to a tertiary care hospital X days after birth. He had an intact manubrium but no corpus of the sternum which had resulted in complete displacement of the heart outside the chest wall (shown in a video). Read the full case details in the Images in Clinical Medicine "Thoracic Ectopia Cordis":"  
[X Link](https://x.com/NEJM/status/1981737664861888582)  2025-10-24T15:00Z 933.1K followers, 41.9K engagements


"Presented at #KidneyWk: In the PISCES trial involving participants receiving hemodialysis fish oil (n3 fatty acids) was compared with corn-oil placebo. The rate of serious cardiovascular events was lower with daily fish-oil supplementation. Full trial results: Editorial: Fish Oil for Patients Receiving Hemodialysis Red Herring or Great Catch @ASNKidney"  
[X Link](https://x.com/NEJM/status/1986834801106821591)  2025-11-07T16:35Z 933K followers, 192.4K engagements


"Bedside clinical skills have been diminished by an overreliance on technology. A new Review Article presents educational strategies for reinvigorating the bedside encounter and shows how much can be learned from it. Read the review Strategies to Reinvigorate the Bedside Clinical Encounter the latest in the Medical Education series by Brian T. Garibaldi MD MEHP and Stephen W. Russell MD from @NUFeinbergMed and the University of Alabama at Birmingham (@UABNews):"  
[X Link](https://x.com/NEJM/status/1989815715147518279)  2025-11-15T22:00Z 933.1K followers, 94K engagements


"Presented at #SVIN25: CREST-2: In high-grade asymptomatic carotid stenosis addition of stenting to medical therapy led to a lower risk of stroke over a 4-year period. Endarterectomy did not lead to a significant benefit. Full results: Editorial: Managing Asymptomatic Carotid Stenosis @svinsociety"  
[X Link](https://x.com/NEJM/status/1991893129390362880)  2025-11-21T15:35Z 933.1K followers, 382.8K engagements


"New in the November XX 2025 issue of NEJM: Early Discontinuation of Aspirin after PCI (TARGET-FIRST trial) Early Withdrawal of Aspirin after PCI (NEO-MINDSET trial) Daily Mosnodenvir as Dengue Prophylaxis CRISPR-Cas9 Targeting ANGPTL3 Engasertib in Hereditary Hemorrhagic Telangiectasia Subscribe to NEJM for the latest medical research:"  
[X Link](https://x.com/NEJM/status/1994043741854945511)  2025-11-27T14:00Z 933K followers, 17.9K engagements


"Original Article: Early Withdrawal of Aspirin after PCI in Acute Coronary Syndromes (NEO-MINDSET trial) Editorial: Discontinuation of Aspirin in Acute Coronary Syndromes Treated with Coronary-Artery Stents #Cardiology"  
[X Link](https://x.com/NEJM/status/1995130812870893617)  2025-11-30T14:00Z 933K followers, 45.5K engagements


"Twelve former commissioners of the FDA express concern that the agencys recent moves will undermine a regulatory model designed to ensure vaccine safety effectiveness and availability. Read the full Perspective:"  
[X Link](https://x.com/NEJM/status/1996341178351092220)  2025-12-03T22:10Z 933.1K followers, 32.7K engagements


"Idiopathic normal-pressure hydrocephalus (iNPH) typically causes gait cognitive and urinary impairment. The diagnosis is aided by a medical evaluation imaging findings and tests that predict improvement with CSF shunting. Learn more in the Review Article Idiopathic Normal-Pressure Hydrocephalus by Mark D. Johnson MD PhD and Michael A. Williams MD from @UMassChan and @UWMedicine:"  
[X Link](https://x.com/NEJM/status/1996348731311219049)  2025-12-03T22:40Z 933.1K followers, 47.6K engagements


"New in the December X 2025 issue of NEJM: Glucocorticoids for Community-Acquired Pneumonia (SONIA trial) Shunting for Idiopathic Normal-Pressure Hydrocephalus (PENS trial) Pegcetacoplan in C3 Glomerulopathy and IC-MPGN (VALIANT phase X trial) Subscribe to NEJM for the latest medical research:"  
[X Link](https://x.com/NEJM/status/1996580404283994393)  2025-12-04T14:00Z 933.1K followers, 35.5K engagements


"Immunizations against Covid-19 RSV and influenza have shown consistent effectiveness and safety and are associated with a substantially reduced risk of hospitalization and severe disease across populations. Findings from a @CIDRAP systematic review underscore the enduring value of immunization against respiratory viruses as a cornerstone of preventive care and support the feasibility of maintaining rigorous evidence-based guidance during periods of institutional disruption. Read the full article:"  
[X Link](https://x.com/NEJM/status/1996655919535739350)  2025-12-04T19:00Z 933K followers, 16.5K engagements


"Presented at #ASH25: In drug-resistant extramedullary myeloma dual treatment with talquetamab and teclistamab produced a response in XX% of patients and 12-month overall survival was 74%; however grade X or X adverse events were common. Full RedirecTT-1 phase 1b2 study results: @ASH_hematology"  
[X Link](https://x.com/NEJM/status/1997781922010079280)  2025-12-07T21:35Z 933.1K followers, 24.6K engagements


"Original Article: Trial of Pegcetacoplan in C3 Glomerulopathy and Immune-Complex MPGN (VALIANT phase X trial) Editorial: Pegcetacoplan for Treatment of C3 Glomerulopathy and Immune-Complex MPGN #Nephrology"  
[X Link](https://x.com/NEJM/status/1998105447744827795)  2025-12-08T19:00Z 933K followers, 10.8K engagements


"In patients with idiopathic normal-pressure hydrocephalus responsive to CSF drainage shunting improved gait and balance at X months but not cognition or incontinence and was associated with some procedure-related risks. Full PENS trial results and Research Summary:"  
[X Link](https://x.com/NEJM/status/1998392381192999070)  2025-12-09T14:00Z 933.1K followers, 17.8K engagements


"Which one of the following choices is the enzyme that is deficient in patients with Pompe disease"  
[X Link](https://x.com/NEJM/status/1998487060425118140)  2025-12-09T20:16Z 933.1K followers, 8422 engagements


"In X of XX patients receiving immune checkpoint inhibitors cell-free DNA methylation profiling revealed multiorgan damage with immune-related adverse events often before symptoms appeared. Learn more:"  
[X Link](https://x.com/NEJM/status/1998882952432988285)  2025-12-10T22:30Z 933.1K followers, 42K engagements


"An 80-year-old man presented to the emergency department with a 12-hour history of pleuritic chest pain and an elevated d-dimer level. A CT scan showed an ulcerlike projection in the ascending thoracic aorta. Read the full case details in the Images in Clinical Medicine article Aortic Intramural Hematoma from Catharina Hospital (@CatharinaZKH):"  
[X Link](https://x.com/NEJM/status/1998890522849792440)  2025-12-10T23:00Z 933.1K followers, 11.6K engagements


"Perspective by Stacie B. Dusetzina PhD and Rachel E. Sachs JD MPH: Insurance Coverage and Pricing of Weight-Loss Drugs in the United States #HealthPolicy #PublicHealth"  
[X Link](https://x.com/NEJM/status/1999237834335748189)  2025-12-11T22:00Z 933.1K followers, 6964 engagements

[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

@NEJM Avatar @NEJM NEJM

NEJM posts on X about events, history, withdrawal, red the most. They currently have XXXXXXX followers and XX posts still getting attention that total XXXXXX engagements in the last XX hours.

Engagements: XXXXXX #

Engagements Line Chart

  • X Week XXXXXXX -XX%
  • X Month XXXXXXX -XX%
  • X Months XXXXXXXXX +78%
  • X Year XXXXXXXXX -XX%

Mentions: XX #

Mentions Line Chart

  • X Week XX +7.70%
  • X Month XX +13%
  • X Months XXX +149%
  • X Year XXX +50%

Followers: XXXXXXX #

Followers Line Chart

  • X Week XXXXXXX +0.14%
  • X Month XXXXXXX -XXXX%
  • X Months XXXXXXX +0.06%
  • X Year XXXXXXX -XXXX%

CreatorRank: XXXXXXX #

CreatorRank Line Chart

Social Influence

Social category influence finance XXXX% countries XXXX%

Social topic influence events #721, history 4.55%, withdrawal 4.55%, red 2.27%, education 2.27%, express 2.27%, level 2.27%, history of 2.27%, insurance 2.27%, united states XXXX%

Top accounts mentioned or mentioned by @ashhematology @erictopol @doc_blocke @vfd_org @svinsociety @nishantuppal7 @drrishabhonco @bllphd @patientstormdoc @dglaucomflecken @nejmevidence @srm128 @asnkidney @nufeinbergmed @uabnews @umasschan @uwmedicine @cidrap @catharinazkh @nbahlis

Top Social Posts

Top posts by engagements in the last XX hours

"Presented at #ASH25: In untreated chronic lymphocytic leukemia fixed-duration venetoclax-based regimens were noninferior to continuous ibrutinib with regard to 3-year progression-free survival and were associated with higher MRD-negative rates. Full CLL17 phase X trial results: @ASH_hematology"
X Link 2025-12-06T13:35Z 933.1K followers, 19.7K engagements

"A trial of pegcetacoplan a C3 and C3b inhibitor in patients with C3 glomerulopathy or primary immune-complex membranoproliferative glomerulonephritis showed that the drug significantly reduced proteinuria. Full VALIANT phase X trial results: Editorial: Pegcetacoplan for Treatment of C3 Glomerulopathy and Immune-Complex MPGN"
X Link 2025-12-03T22:30Z 933.1K followers, 13.7K engagements

"Treatments are needed for C3 glomerulopathy and primary immune-complex membranoproliferative glomerulonephritis. Pegcetacoplan a targeted C3 and C3b inhibitor showed promise in phase X trials. Research findings from the VALIANT phase X trial are summarized in a new Quick Take video"
X Link 2025-12-07T20:00Z 933.1K followers, 14.5K engagements

"Presented at #ASH25: In relapsed or refractory T-cell acute lymphoblastic leukemia off-the-shelf allogeneic base-edited CAR7 T cells mediated responses in XX patients enabling stem-cell transplantation in X patients in deep remission. Full study results: @ASH_hematology"
X Link 2025-12-08T21:35Z 933.1K followers, 38.4K engagements

"Presented at #ASH25: In a new study gene editing with a prime editor was used to treat two persons with chronic granulomatous disease caused by a small deletion in the gene NCF1. Full study results: @ASH_hematology"
X Link 2025-12-07T13:05Z 933.1K followers, 31.8K engagements

"Original Article: Fixed-Duration versus Continuous Treatment for Chronic Lymphocytic Leukemia (CLL17 phase X trial) #ASH25 @ASH_hematology"
X Link 2025-12-07T14:04Z 933.1K followers, 32.6K engagements

"Brief Report: Prime Editing for p47-Deficient Chronic Granulomatous Disease #ASH25 @ASH_hematology"
X Link 2025-12-08T12:58Z 933.1K followers, 14.7K engagements

"Presented at #ASH25: In the VAYHIT2 phase X trial ianalumab plus eltrombopag led to a longer time to treatment failure than placebo plus eltrombopag with a stable platelet response at X months in a higher percentage of patients with X mg/kg of ianalumab than with placebo. Full trial results: @ASH_hematology"
X Link 2025-12-09T12:35Z 933.1K followers, 13.1K engagements

"A new trial of pegcetacoplan a C3 and C3b inhibitor in patients with C3 glomerulopathy or primary immune-complex membranoproliferative glomerulonephritis showed that the drug significantly reduced proteinuria. Full VALIANT phase X trial results and Research Summary:"
X Link 2025-12-10T14:00Z 933.1K followers, 8851 engagements

"A 26-year-old woman was referred to the pulmonary hypertension clinic with a 6-month history of exertional dyspnea and hoarseness. Vocal-fold paralysis was seen on laryngoscopy (shown in a video). Read the full case details:"
X Link 2025-11-25T20:00Z 932.9K followers, 636.8K engagements

"Original Article: Early Discontinuation of Aspirin after PCI in Low-Risk Acute Myocardial Infarction (TARGET-FIRST trial) Editorial: Discontinuation of Aspirin in Acute Coronary Syndromes Treated with Coronary-Artery Stents #Cardiology"
X Link 2025-11-29T14:00Z 932.8K followers, 35.9K engagements

"In a new trial one dose of an HPV vaccine was noninferior to two doses in preventing HPV type XX or XX infection. Full ESCUDDO trial results: Editorial: Evidence to Action Single-Dose HPV Vaccination and Cervical HPV Infection"
X Link 2025-12-03T22:15Z 933K followers, 15.8K engagements

"A baby boy was transferred to a tertiary care hospital X days after birth. He had an intact manubrium but no corpus of the sternum which had resulted in complete displacement of the heart outside the chest wall (shown in a video). Read the full case details in the Images in Clinical Medicine "Thoracic Ectopia Cordis":"
X Link 2025-10-24T15:00Z 933.1K followers, 41.9K engagements

"Presented at #KidneyWk: In the PISCES trial involving participants receiving hemodialysis fish oil (n3 fatty acids) was compared with corn-oil placebo. The rate of serious cardiovascular events was lower with daily fish-oil supplementation. Full trial results: Editorial: Fish Oil for Patients Receiving Hemodialysis Red Herring or Great Catch @ASNKidney"
X Link 2025-11-07T16:35Z 933K followers, 192.4K engagements

"Bedside clinical skills have been diminished by an overreliance on technology. A new Review Article presents educational strategies for reinvigorating the bedside encounter and shows how much can be learned from it. Read the review Strategies to Reinvigorate the Bedside Clinical Encounter the latest in the Medical Education series by Brian T. Garibaldi MD MEHP and Stephen W. Russell MD from @NUFeinbergMed and the University of Alabama at Birmingham (@UABNews):"
X Link 2025-11-15T22:00Z 933.1K followers, 94K engagements

"Presented at #SVIN25: CREST-2: In high-grade asymptomatic carotid stenosis addition of stenting to medical therapy led to a lower risk of stroke over a 4-year period. Endarterectomy did not lead to a significant benefit. Full results: Editorial: Managing Asymptomatic Carotid Stenosis @svinsociety"
X Link 2025-11-21T15:35Z 933.1K followers, 382.8K engagements

"New in the November XX 2025 issue of NEJM: Early Discontinuation of Aspirin after PCI (TARGET-FIRST trial) Early Withdrawal of Aspirin after PCI (NEO-MINDSET trial) Daily Mosnodenvir as Dengue Prophylaxis CRISPR-Cas9 Targeting ANGPTL3 Engasertib in Hereditary Hemorrhagic Telangiectasia Subscribe to NEJM for the latest medical research:"
X Link 2025-11-27T14:00Z 933K followers, 17.9K engagements

"Original Article: Early Withdrawal of Aspirin after PCI in Acute Coronary Syndromes (NEO-MINDSET trial) Editorial: Discontinuation of Aspirin in Acute Coronary Syndromes Treated with Coronary-Artery Stents #Cardiology"
X Link 2025-11-30T14:00Z 933K followers, 45.5K engagements

"Twelve former commissioners of the FDA express concern that the agencys recent moves will undermine a regulatory model designed to ensure vaccine safety effectiveness and availability. Read the full Perspective:"
X Link 2025-12-03T22:10Z 933.1K followers, 32.7K engagements

"Idiopathic normal-pressure hydrocephalus (iNPH) typically causes gait cognitive and urinary impairment. The diagnosis is aided by a medical evaluation imaging findings and tests that predict improvement with CSF shunting. Learn more in the Review Article Idiopathic Normal-Pressure Hydrocephalus by Mark D. Johnson MD PhD and Michael A. Williams MD from @UMassChan and @UWMedicine:"
X Link 2025-12-03T22:40Z 933.1K followers, 47.6K engagements

"New in the December X 2025 issue of NEJM: Glucocorticoids for Community-Acquired Pneumonia (SONIA trial) Shunting for Idiopathic Normal-Pressure Hydrocephalus (PENS trial) Pegcetacoplan in C3 Glomerulopathy and IC-MPGN (VALIANT phase X trial) Subscribe to NEJM for the latest medical research:"
X Link 2025-12-04T14:00Z 933.1K followers, 35.5K engagements

"Immunizations against Covid-19 RSV and influenza have shown consistent effectiveness and safety and are associated with a substantially reduced risk of hospitalization and severe disease across populations. Findings from a @CIDRAP systematic review underscore the enduring value of immunization against respiratory viruses as a cornerstone of preventive care and support the feasibility of maintaining rigorous evidence-based guidance during periods of institutional disruption. Read the full article:"
X Link 2025-12-04T19:00Z 933K followers, 16.5K engagements

"Presented at #ASH25: In drug-resistant extramedullary myeloma dual treatment with talquetamab and teclistamab produced a response in XX% of patients and 12-month overall survival was 74%; however grade X or X adverse events were common. Full RedirecTT-1 phase 1b2 study results: @ASH_hematology"
X Link 2025-12-07T21:35Z 933.1K followers, 24.6K engagements

"Original Article: Trial of Pegcetacoplan in C3 Glomerulopathy and Immune-Complex MPGN (VALIANT phase X trial) Editorial: Pegcetacoplan for Treatment of C3 Glomerulopathy and Immune-Complex MPGN #Nephrology"
X Link 2025-12-08T19:00Z 933K followers, 10.8K engagements

"In patients with idiopathic normal-pressure hydrocephalus responsive to CSF drainage shunting improved gait and balance at X months but not cognition or incontinence and was associated with some procedure-related risks. Full PENS trial results and Research Summary:"
X Link 2025-12-09T14:00Z 933.1K followers, 17.8K engagements

"Which one of the following choices is the enzyme that is deficient in patients with Pompe disease"
X Link 2025-12-09T20:16Z 933.1K followers, 8422 engagements

"In X of XX patients receiving immune checkpoint inhibitors cell-free DNA methylation profiling revealed multiorgan damage with immune-related adverse events often before symptoms appeared. Learn more:"
X Link 2025-12-10T22:30Z 933.1K followers, 42K engagements

"An 80-year-old man presented to the emergency department with a 12-hour history of pleuritic chest pain and an elevated d-dimer level. A CT scan showed an ulcerlike projection in the ascending thoracic aorta. Read the full case details in the Images in Clinical Medicine article Aortic Intramural Hematoma from Catharina Hospital (@CatharinaZKH):"
X Link 2025-12-10T23:00Z 933.1K followers, 11.6K engagements

"Perspective by Stacie B. Dusetzina PhD and Rachel E. Sachs JD MPH: Insurance Coverage and Pricing of Weight-Loss Drugs in the United States #HealthPolicy #PublicHealth"
X Link 2025-12-11T22:00Z 933.1K followers, 6964 engagements

creator/x::NEJM
/creator/x::NEJM